补偿性大质体凸起:一种新的观察及其对肉毒神经毒素注射技术的影响
Kyu-Ho Yi1,2, Jovian Wan3
1You and I Clinic, Seoul, Korea.
Journal of cosmetic dermatology
|April 7, 2025
概括
在注射肉毒神经毒素后,可以出现补偿性体凸起. 一种新的分层技术,使用超声波,处理所有肌肉层,以防止面部不对称.
科学领域:
- 审美医学是一种美学医学.
- 面部解剖学 面部解剖学
- 神经调节器治疗疗法 神经调节器治疗
背景情况:
- 补偿性肌肉突起是针对下部肌肉突起的肉毒神经毒素 (BoNT) 注射的新型并发症.
- 上层体层的这种过度缩小是由于削弱的下部区域的补偿机制造成的,导致面部不对称.
- 传统的注射方法往往忽视了按摩器的三层解剖结构 (表面,中间,深层),增加了不对称的风险.
研究的目的:
- 引入一种新的逆行,分层注射技术,用于将BoNT注入按摩器肌肉.
- 为了防止补偿性质体凸起,并改善面部对称性.
- 突出解剖学精度的重要性和量身定制的剂量在masseter缩管理.
主要方法:
- 建议采用反向的,分层的注射方法,确保BoNT在所有质层中均分布.
- 超声指导用于精确的毒素输送,准特定的肌肉层,避免邻近的结构.
- 实施个性化剂量策略,考虑个体肌肉厚度,活动和先前治疗史,以防止过度缩.
主要成果:
- 一个34岁的女性的案例研究表明,在连续的下面的masseter BoNT治疗后,上部masseter缩 (12毫米).
- 超声波成像证实了上层的缩和下层的缩.
- 通过分层技术用50个单位的莱蒂博胺毒素A治疗,将上部器的厚度降低到8毫米,成功恢复了面部对称性.
结论:
- 补偿性膨胀需要一个全面的治疗方法,以解决整个按摩器肌肉.
- 由超声波指导和个性化剂量增强的分层注射有效地减轻了面部不对称的风险.
- 临床医生应该整合详细的解剖学知识和先进的成像,以获得最佳的结果,在管理masseter缩.
相关概念视频
01:31Skeletal Muscle Relaxants: Therapeutic Uses
444
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
444
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
632
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
632
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
371
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
371
01:21Skeletal Muscle Relaxants: Adverse Effects
322
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
322
01:14Muscles for Facial Expressions
1.7K
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
1.7K